Table 3.
Comparison | Revised statement tested | New informationb |
Self-reported learningc |
Thinking about risksd |
||||||
---|---|---|---|---|---|---|---|---|---|---|
Revised: % describing as new information | TCA: % describing as new information | OR (95% CI) | Revised: mean (SD) | TCA: mean (SD) | Regression coefficient (95% Cl) | Revised: % think about risk | TCA: % think about risk | OR (95% Cl) | ||
| ||||||||||
1 | Mouth and throat cancer | 12.9 | 12.2 | 1.07 (0.54 to 2.15) | 2.51 (2.09) | 2.39 (2.08) | 0.13 (−0.39 to 0.65) | 68.0 | 68.9 | 0.96 (0.59 to 1.58) |
2 | Head and neck cancer | 64.2 | 12.2 | 13.26 (7.20 to 24.4)a | 3.92 (1.77) | 2.39 (2.08) | 1.52 (1.05 to 1.99)a | 68.9 | 68.9 | 1.00 (0.61 to 1.64) |
3 | Bladder cancer | 78.9 | 12.2 | 28.15 (14.74 to 53.72)a | 4.19 (1.86) | 2.39 (2.08) | 1.81 (1.33 to 2.28)a | 70.8 | 68.9 | 1.10 (0.66 to 1.81) |
4 | Premature birth | 17.6 | 8.8 | 2.28 (1.09 to 4.75)a | 2.94 (2.24) | 2.43 (2.17) | 0.52 (−0.01 to 1.04) | 64.9 | 70.9 | 0.76 (0.46 to 1.24) |
5 | Stunt fetal growth | 19.0 | 8.8 | 2.49 (1.21 to 5.13)a | 3.17(2.22) | 2.43 (2.17) | 0.75 (0.21 to 1.28)a | 68.0 | 70.9 | 0.87 (0.53 to 1.44) |
6 | Low birth weight | 19.0 | 8.8 | 2.47 (1.21 to 5.03)a | 2.93 (2.17) | 2.43 (2.17) | 0.52 (0.00 to 1.03) | 68.0 | 70.9 | 0.87 (0.52 to 1.44) |
7 | Respiratory illness in children | 31.8 | 23.0 | 1.56 (0.93 to 2.63) | 3.30 (1.95) | 2.56 (2.15) | 0.73 (0.25 to 1.21)a | 74.3 | 68.9 | 1.31 (0.79 to 2.17) |
8 | Clogged arteries | 32.0 | 16.2 | 2.50 (1.41 to 4.43)a | 3.36(2.03) | 2.70 (1.96) | 0.66 (0.19 to 1.13)a | 64.6 | 66.9 | 0.90 (0.56 to 1.47) |
9 | COPDe | 36.7 | 41.9 | 0.80 (0.50 to 1.29) | 3.26(2.03) | 2.86 (1.99) | 0.41 (−0.07 to 0.88) | 71.4 | 56.8 | 1.94 (1.19 to 3.17)a |
10 | COPDf | 29.3 | 16.2 | 2.14 (1.22 to 3.77)a | 3.38 (2.00) | 2.33 (2.07) | 1.05 (0.56 to 1.53)a | 76.9 | 61.5 | 2.13 (1.27 to 3.56)a |
11 | Emphysema and bronchitis | 22.4 | 16.2 | 1.50 (0.83 to 2.72) | 3.19(2.22) | 2.33 (2.07) | 0.86 (0.35 to 1.38)a | 78.2 | 61.5 | 2.29 (1.36 to 3.84)a |
12 | Erectile dysfunction | 69.4 | 8.8 | 24.43 (12.26 to 48.66)a | 3.85 (1.87) | 2.43 (2.17) | 1.42 (0.93 to 1.90)a | 55.1 | 70.9 | 0.50 (0.30 to 0.81)a |
13 | Amputation | 66.2 | 16.2 | 10.79 (6.10 to 19.08)a | 4.23 (1.78) | 2.70 (1.96) | 1.53 (1.09 to 1.97)a | 77.7 | 66.9 | 1.75 (1.04 to 2.96) |
14 | Diabetes | 75.5 | 16.2 | 16.01 (8.97 to 28.57)a | 3.90 (1.92) | 2.33 (2.07) | 1.56 (1.09 to 2.03)a | 56.5 | 61.5 | 0.81 (0.51 to 1.30) |
15 | Macular degeneration | 75.5 | 8.8 | 36.90 (17.66 to 77.07)a | 4.38 (1.72) | 2.25 (2.17) | 2.12 (1.64 to 2.60)a | 71.4 | 55.4 | 2.01 (1.24 to 3.26)a |
16 | Cataracts | 79.7 | 8.8 | 42.61 (20.73 to 87.55)a | 4.28 (1.81) | 2.43 (2.17) | 1.85 (1.38 to 2.33)a | 64.2 | 70.9 | 0.73 (0.45 to 1.20) |
Regressions control for age group. Cl = confidence interval; COPD = chronic obstructive pulmonary disease; OR = odds ratio; TCA = Tobacco Control Act.
“Significant after adjustment for multiple comparisons.
Participants responded “no” or “not sure” (instead of “yes”) to the question, “Before today, had you heard about the specific smoking-related health effect described in the warning statement?”
Scale from 1 = “Not at all” to 7 = “Very much.”
“Not at all” or “A little” coded as 1 and “Somewhat” or “A lot” coded as 0.
Compared with fatal lung disease in nonsmokers.
Compared with fatal lung disease in smokers.